Reducing the risk of atherosclerosis: The role of high-density lipoprotein cholesterol

British Journal of Cardiology

Volumn 11, Issue SUPPL. 2, 2004, Pages

  Libby, Peter ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antioxidant enzymes; Cholesteryl ester transfer protein; High density lipoprotein; Niacin; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER; ANTIOXIDANT; CHOLESTEROL ESTER TRANSFER PROTEIN; CLOFIBRATE; ENZYME; ESTROGEN; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; NICOTINIC ACID; PLACEBO; SCAVENGER RECEPTOR; THYROXINE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; DRUG MECHANISM; HEART DEATH; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID DEGRADATION; LIPID METABOLISM; RISK MANAGEMENT; TANGIER DISEASE;

EID: 1342268272     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Castelli W. Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol 1988;4(suppl A):5a-10a.
2. Brooks-Wilson A, Marcil M, Clee SM et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-45.
3. Bodzioch M, Orso E, Klucken J et al. The gene encoding ATP-binding cassette transporter is mutated in Tangier disease. Nat Genet 1999;22:347-51.
4. Rust S, Rosier M, Funke H et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999;22:352-5.
5. Young SG, Fielding CJ. The ABCs of cholesterol efflux. Nat Genet 1999; 22:316-18.
6. Acton S, Rigotti A, Landschulz K et al. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 1996;271:518-20.
7. Libby P. HDL-C and reducing the risk of atherosclerosis: a mechanistic review. Clinician 2000;18:3-8.
8. Navab M, Berliner JA, Watson AD et al. The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. ATVB 1996;16:831.
9. Barter PJ, Brewer HB, Chapman MJ et al. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. ATVB 2003;23:160.
10. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 1975;231:360-81.
11. Hunninghake DB, McGovern ME, Koren M et al. A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and ovastatin. Clin Cardiol 2003;26:112-18.
12. Wise A, Foord SM, Fraser NJ et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003;278:2849-74.
13. Soga T, Kamohara M, Takasaki J et al. Molecular identification of nicotinic acid receptor. Biochem Biophys Res Comm 2003;303:364-9.